ERVK-7

ERVK-7 encodes an endogenous retroviral Gag polyprotein (common alias: ERVK-7 Gag), which retains structural domains for capsid assembly and nucleic acid binding. Its mechanism involves potential roles in modulating host innate immunity—interacting with pattern recognition receptors like TLRs to regulate inflammatory responses, though its exact physiological function remains partially characterized.
Dysregulated ERVK-7 expression is linked to autoimmune disorders (e.g., systemic lupus erythematosus) and certain cancers (e.g., breast carcinoma). No targeted drugs exist yet, but preclinical studies are investigating protease inhibitors that target conserved retroviral domains in ERVK-7 Pol to mitigate pathologies associated with its reactivation.